Scott Lowe
Papers
1
Total Citations
20
H-Index
1
About
Dr. Scott Lowe is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for gastric cancer treatment, particularly within the framework of Enhanced Recovery After Surgery (ERAS) protocols. His major contribution lies in rigorously comparing the short-term efficacy and safety of total robotic distal gastrectomy (TRDG) against 3D total laparoscopic distal gastrectomy (3D-TLDG), providing critical evidence to guide surgical decision-making. His landmark 2023 study, which has already garnered 20 citations, employed propensity score matching to demonstrate that both approaches are safe and effective under ERAS, yet highlighted nuanced differences in recovery outcomes. This work is pivotal for surgeons seeking to optimize patient recovery while minimizing complications. Dr. Lowe’s research directly impacts clinical practice by clarifying the role of advanced robotic platforms in gastrointestinal oncology. His dedication to evidence-based surgery and patient-centered recovery continues to shape the future of gastric cancer care, making him a respected voice in the field of surgical innovation.
Research Focus
Key Achievements
Top Papers
- 1